A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

ClinicalTrials.gov ID: NCT07201051

Public ClinicalTrials.gov record NCT07201051. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Investigate Efficacy, Safety, Immunogenicity, and Pharmacokinetics, of GSK3862995B in Participants With Bronchiectasis

Study identification

NCT ID: NCT07201051
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: GlaxoSmithKline; Industry
Enrollment: 446 participants

Conditions and interventions

Conditions

Bronchiectasis

Interventions

GSK3862995B Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 85 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 29, 2025
Primary completion: May 3, 2027
Completion: Dec 9, 2027
Last update posted: Jul 7, 2026

2025 – 2027

United States locations

U.S. sites: 14
U.S. states: 7
U.S. cities: 13

Facility	City	State	ZIP	Site status
GSK Investigational Site	Mobile	Alabama	36608	Recruiting
GSK Investigational Site	La Palma	California	90623	Recruiting
GSK Investigational Site	Miami	Florida	33126	Recruiting
GSK Investigational Site	Miami	Florida	33176	Recruiting
GSK Investigational Site	Naples	Florida	34102	Recruiting
GSK Investigational Site	Plantation	Florida	33324	Recruiting
GSK Investigational Site	St. Petersburg	Florida	33707	Recruiting
GSK Investigational Site	Rockville	Maryland	20854	Recruiting
GSK Investigational Site	DuBois	Pennsylvania	15801	Recruiting
GSK Investigational Site	Anderson	South Carolina	29621	Recruiting
GSK Investigational Site	Rock Hill	South Carolina	29732	Recruiting
GSK Investigational Site	Spartanburg	South Carolina	29303	Recruiting
GSK Investigational Site	Conroe	Texas	77384	Recruiting
GSK Investigational Site	Sugar Land	Texas	77479	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07201051, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 7, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07201051 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →